UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Prostate cancer and prostatic diseases, 2018-04, Vol.21 (1), p.57-63

2018

Volltextzugriff (PDF)

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

Journal of magnetic resonance imaging, 2024-08, Vol.60 (2), p.458-468

2024

Volltextzugriff (PDF)

Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

Value in health, 2021-12, Vol.24 (12), p.1763-1772

2021

Volltextzugriff (PDF)

Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions

JNCI : Journal of the National Cancer Institute, 2016-12, Vol.108 (12), p.djw165

2016

Volltextzugriff (PDF)

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

JAMA oncology, 2022-07, Vol.8 (7), p.1019

2022

Volltextzugriff (PDF)

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

Journal of clinical pathology, 2020-10, Vol.73 (10), p.630-635

2020

Volltextzugriff (PDF)

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

JNCI : Journal of the National Cancer Institute, 2021-05, Vol.113 (5), p.632-640

2021

Volltextzugriff (PDF)

Association between PSA density and prostate cancer in men without significant MRI lesions

BJU international, 2020-06, Vol.125 (6), p.763-764

2020

Volltextzugriff (PDF)

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

Prostate cancer and prostatic diseases, 2019-03, Vol.22 (1), p.137-142

2019

Volltextzugriff (PDF)

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study

JAMA oncology, 2023-01, Vol.9 (1), p.88

2023

Volltextzugriff (PDF)

Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy-A 10-year population-based cohort study

The Prostate, 2015-06, Vol.75 (9), p.947-956

2015

Volltextzugriff (PDF)

The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments

Nature reviews. Clinical oncology, 2016-06, Vol.13 (6), p.394-394

2016

Volltextzugriff (PDF)

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

The New England journal of medicine, 2021-09, Vol.385 (10), p.908-920

2021

Volltextzugriff (PDF)

Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists

JNCI : Journal of the National Cancer Institute, 2024-09, Vol.116 (9), p.1459-1465

2024

Volltextzugriff (PDF)

MRI-Targeted Biopsy in Prostate Cancer Screening. Reply

The New England journal of medicine, 2021-11, Vol.385 (22), p.2110-2111

2021

Volltextzugriff (PDF)

MP58-03 PROSTATE CANCER SCREENING - A NOVEL RISK PREDICTION TOOL WITH STANDARD BIOPSIES VS. PSA WITH MRI-TARGETED BIOPSIES

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

PD03-02 LONG-TERM EFFECTS OF 5Α-REDUCTASE INHIBITORS ON PROSTATE CANCER MORTALITY - A LARGE POPULATION-BASED PROSPECTIVE STUDY

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial

JAMA network open, 2024-02, Vol.7 (2), p.e2354577-e2354577

2024

Volltextzugriff (PDF)

Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial

JAMA network open, 2024-04, Vol.7 (4), p.e247131-e247131

2024

Volltextzugriff (PDF)

Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer

The Prostate, 2016-03, Vol.76 (4), p.339-348

2016

Volltextzugriff (PDF)

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy

JAMA network open, 2023-09, Vol.6 (9), p.e2332900

2023

Volltextzugriff (PDF)

MP17-06 VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESPONSE

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Volltextzugriff (PDF)

PD53-09 DISCRIMINATION AND CALIBRATION OF THE STOCKHOLM3 MODEL WITH MRI-TARGETED BIOPSIES

The Journal of urology, 2020-04, Vol.203, p.e1100

2020

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(59)
Tagungsberichte
(6)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

Association between PSA density and prostate cancer in men without significant MRI lesions

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study

Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy-A 10-year population-based cohort study

The STHLM3 prostate cancer diagnostic study: calibration, clarification, and comments

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists

MRI-Targeted Biopsy in Prostate Cancer Screening. Reply

MP58-03 PROSTATE CANCER SCREENING - A NOVEL RISK PREDICTION TOOL WITH STANDARD BIOPSIES VS. PSA WITH MRI-TARGETED BIOPSIES

PD03-02 LONG-TERM EFFECTS OF 5Α-REDUCTASE INHIBITORS ON PROSTATE CANCER MORTALITY - A LARGE POPULATION-BASED PROSPECTIVE STUDY

Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non‐metastatic high‐risk prostate cancer (SPCG 19/GRand‐P)

Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial

Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial

Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy

MP17-06 VALIDATION OF EAU RISK GROUPS FOR BIOCHEMICAL RECURRENCE AFTER RADIOTHERAPY AND RADICAL PROSTATECTOMY FOR PREDICTION OF PROSTATE CANCER MORTALITY

PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESPONSE

PD53-09 DISCRIMINATION AND CALIBRATION OF THE STOCKHOLM3 MODEL WITH MRI-TARGETED BIOPSIES

Aktive Filter

Suchergebnisse filtern